Robotic total intersphincteric resection with total mesorectal excision in low rectal cancer – a video vignette

2020 ◽  
Vol 22 (12) ◽  
pp. 2344-2345
Author(s):  
B. R. Kumar ◽  
D. Pandey ◽  
S. Bankar ◽  
J. Rohila ◽  
A. DeSouza ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Total Mesorectal Excision ◽  
Intersphincteric Resection ◽  
Low Rectal Cancer ◽  
Mesorectal Excision ◽  
Video Vignette

Transanal total mesorectal excision with D3 para‐aortic lymph node dissection for low rectal cancer – a video vignette

2019 ◽  
Vol 22 (2) ◽  
pp. 230-231
Author(s):  
R. Hompes ◽  
S. K. Efetov ◽  
I. A. Tulina ◽  
Y. E. Kitsenko ◽  
A. A. Pokshubina ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Lymph Node ◽  
Total Mesorectal Excision ◽  
Lymph Node Dissection ◽  
Low Rectal Cancer ◽  
Transanal Total Mesorectal Excision ◽  
Node Dissection ◽  
Mesorectal Excision ◽  
Aortic Lymph Node ◽  
Video Vignette

Laparoscopic Total Mesorectal Excision for low rectal cancer ‐ A step by step approach

2021 ◽  
Author(s):  
Naveena AN Kumar ◽  
Nawaz Usman ◽  
Keshava Rajan ◽  
Preethi S Shetty ◽  
Vilas HV Crithic ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Total Mesorectal Excision ◽  
Low Rectal Cancer ◽  
Laparoscopic Total Mesorectal Excision ◽  
Mesorectal Excision

Don't be stumped by the stent: transanal total mesorectal excision in the resection of a stented rectal cancer - a video vignette

2018 ◽  
Vol 20 (10) ◽  
pp. 937-937
Author(s):  
A. Saracino ◽  
E. Courtney ◽  
S. Dalton ◽  
J. Bunni
Keyword(s):  
Rectal Cancer ◽  
Total Mesorectal Excision ◽  
Transanal Total Mesorectal Excision ◽  
Mesorectal Excision ◽  
Video Vignette

scholarly journals Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk

2019 ◽  
Vol 17 (1) ◽  
Author(s):  
I-Li Lai ◽  
Jeng-Fu You ◽  
Yih-Jong Chern ◽  
Wen-Sy Tsai ◽  
Jy-Ming Chiang ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Adjuvant Therapy ◽  
Total Mesorectal Excision ◽  
Local Excision ◽  
Therapy Group ◽  
Low Rectal Cancer ◽  
Survival Outcomes ◽  
Mesorectal Excision ◽  
Alternative Treatment Option ◽  
Late Morbidity

Abstract Background Local excision (LE) is a feasible treatment approach for rectal cancers in stage pT1 and presents low pathological risk, whereas total mesorectal excision (TME) is a reasonable treatment for more advanced cancers. On the basis of the pathology findings, surgeons may suggest TME for patients receiving LE. This study compared the survival outcomes between LE with/without chemoradiation and TME in mid and low rectal cancer patients in stage pT1/pT2, with highly selective intermediate pathological risk. Methods This retrospective study included 134 patients who received TME and 39 patients who underwent LE for the treatment of intermediate risk (pT1 with poor differentiation, lymphovascular invasion, perineural invasion, relatively large tumor, or small-sized pT2 tumor) rectal cancer between 1998 and 2016. Results Overall survival (OS), disease-free survival (DFS), and cumulative recurrence rate (CRR) were similar between the LE (3-year DFS 92%) and TME (3-year DFS 91%) groups. Following subgrouping into an LE with adjuvant therapy group and a TME without adjuvant therapy group, the compared survival outcomes (OS, DFS, and CRR) were found not to be statistically different. The temporary and permanent ostomy rates were higher in the TME group than in the LE group (p < 0.001). Rates of early and late morbidity following surgery were higher in the TME group (p = 0.005), and LE had similar survival compared with TME. Conclusion For patients who had mid and low rectal cancer in stage pT1/pT2 and intermediate pathological risk, LE with chemoradiation presents an alternative treatment option for selected patients.

Sign in / Sign up

Export Citation Format

Share Document